4//SEC Filing
Adams Respiratory Therapeutics, Inc. 4
Accession 0001209191-07-038910
CIK 0001319439operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:48 PM ET
Size
9.3 KB
Accession
0001209191-07-038910
Insider Transaction Report
Form 4
Casale Robert Daniel
EVP, Chief Mktg & Devel. Off.
Transactions
- Sale
Common Stock
2007-06-25$40.51/sh−3,000$121,530→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-06-25−3,000→ 51,960 totalExercise: $1.42Exp: 2014-02-27→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2007-06-25$1.42/sh+3,000$4,260→ 3,000 total
Footnotes (2)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2007.
- [F2]The option vests in prorata monthly installments over five years, beginning on April 1, 2004.
Documents
Issuer
Adams Respiratory Therapeutics, Inc.
CIK 0001319439
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001319439
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:48 PM ET
- Size
- 9.3 KB